Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IDEAYA Biosciences (IDYA) FCF Margin: 2020-2025

Historic FCF Margin for IDEAYA Biosciences (IDYA) over the last 3 years, with Sep 2025 value amounting to 68.41%.

  • IDEAYA Biosciences' FCF Margin was N/A to 68.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -46.47%, marking a year-over-year change of. This contributed to the annual value of -3,592.01% for FY2024, which is 308916.00% down from last year.
  • As of Q3 2025, IDEAYA Biosciences' FCF Margin stood at 68.41%, which was up 103.90% from -1,753.67% recorded in Q4 2024.
  • IDEAYA Biosciences' FCF Margin's 5-year high stood at 68.41% during Q3 2025, with a 5-year trough of -1,753.67% in Q4 2024.
  • Moreover, its 3-year median value for FCF Margin was -504.88% (2023), whereas its average is -667.84%.
  • As far as peak fluctuations go, IDEAYA Biosciences' FCF Margin crashed by 114,935bps in 2021, and later soared by 5,893bps in 2022.
  • Over the past 5 years, IDEAYA Biosciences' FCF Margin (Quarterly) stood at -582.78% in 2021, then skyrocketed by 173bps to -581.05% in 2022, then slumped by 4,582bps to -626.87% in 2023, then tumbled by 112,680bps to -1,753.67% in 2024, then reached 68.41% in 2025.
  • Its FCF Margin stands at 68.41% for Q3 2025, versus -1,753.67% for Q4 2024 and -626.87% for Q4 2023.